Trump defends hydroxychloroquine use by claiming NIH-funded study was actually 'phony'
President Trump is creating his own facts to defend taking hydroxychloroquine.
Trump said Monday that he is taking the potentially toxic malaria drug as a "preventative" measure against COVID-19, though a note from Trump's doctor didn't actually say he was doing so. Still, Trump doubled down on the drug on Tuesday, declaring that a government-funded study that showed hydroxychloroquine's dangers was actually "false" and "phony."
"That was a false study, where they gave it to very sick people," Trump said, seemingly talking about research that showed hundreds of COVID-19 patients at VA hospitals not only didn't see improvement after taking hydroxychloroquine, but also ended up with a higher death rate. "It was given by obviously not friends of the administration," Trump said of the research funded by the National Institutes of Health and the University of Virginia.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Dr. Eric Fiegl-Ding, an epidemiologist at Harvard University, declared in a tweet that Trump's criticism of the study was actually "100% HORSE SH*T." And David Shulkin, the former secretary of veterans affairs under Trump, responded to the president's Tuesday comments with concerns of his own. Kathryn Krawczyk
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Could a part-and-part mortgage help you on to the property ladder?Combining repayment and interest-only mortgages could become more popular as part of a push towards more flexible lending
-
Is social media over?Today’s Big Question We may look back on 2025 as the moment social media jumped the shark
-
Should parents stop tracking their kids?Talking Point Experts warn the line between care and control is getting murkier – and could have consequences
-
Hegseth moves to demote Sen. Kelly over videospeed read Retired Navy fighter pilot Mark Kelly appeared in a video reminding military service members that they can ‘refuse illegal orders’
-
Trump says US ‘in charge’ of Venezuela after Maduro grabSpeed Read The American president claims the US will ‘run’ Venezuela for an unspecified amount of time, contradicting a statement from Secretary of State Marco Rubio
-
Bari Weiss’ ‘60 Minutes’ scandal is about more than one reportIN THE SPOTLIGHT By blocking an approved segment on a controversial prison holding US deportees in El Salvador, the editor-in-chief of CBS News has become the main story
-
CBS pulls ‘60 Minutes’ report on Trump deporteesSpeed Read An investigation into the deportations of Venezuelan migrants to El Salvador’s notorious prison was scrapped
-
Trump administration posts sliver of Epstein filesSpeed Read Many of the Justice Department documents were heavily redacted, though new photos of both Donald Trump and Bill Clinton emerged
-
Trump HHS moves to end care for trans youthSpeed Read The administration is making sweeping proposals that would eliminate gender-affirming care for Americans under age 18
-
Jack Smith tells House of ‘proof’ of Trump’s crimesSpeed Read President Donald Trump ‘engaged in a criminal scheme to overturn the results of the 2020 presidential election,’ hoarded classified documents and ‘repeatedly tried to obstruct justice’
-
House GOP revolt forces vote on ACA subsidiesSpeed Read The new health care bill would lower some costs but not extend expiring Affordable Care Act subsidies
